Financials

  • Market Capitalization 20.48 M
  • Employee 29
  • Founded 1986
  • CEO Carl Spana
  • Website www.palatin.com
  • Headquarter New Jersey, United States
  • FIGI BBG000BN9PY4
  • Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
4.79
Rapporto prezzo/fatturato
1.91

Related tickers

#NomePrezzo24h %7d %1M %1Y %Valore di MercatoUltimi 7 Giorni
4536
COCP
Cocrystal Pharma, Inc. - Common Stock
1.12 USD-3.45%-0.88%+28.74%-27.74%21.57 M USD
4539
KZIA
Kazia Therapeutics Limited - American Depositary Shares
12.71 USD-7.70%-7.83%-0.70%+117.26%20.58 M USD
4547
NEUP
Neuphoria Therapeutics Inc. - Common Stock
3.80 USD+1.06%-1.55%-1.55%-66.46%20.54 M USD
4552
ENLV
Enlivex Ltd. - Ordinary Shares
1.27 USD-0.78%-16.45%-40.65%+22.12%20.10 M USD

Notizie